Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and Chemotherapy for Inoperable Cholangiocarcinoma
NCT00779454Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Sep 2008
- Primary completion
- Mar 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in cholangiocarcinoma (CCA), sponsored by Vejle Hospital. Started Sep 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00779454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779454.